| 000 | 01818 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517114214.0 | ||
| 264 | 0 | _c20180206 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.11552 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRenner, Guillaume | |
| 245 | 0 | 0 |
_aExpression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells. _h[electronic resource] |
| 260 |
_bOncotarget _cSep 2016 |
||
| 300 |
_a62194-62207 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aBrain Neoplasms _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCell Movement |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aEpithelial-Mesenchymal Transition _xdrug effects |
| 650 | 0 | 4 |
_aFibronectins _xmetabolism |
| 650 | 0 | 4 |
_aGlioma _xgenetics |
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 3-Ring _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aIntegrin alpha5beta1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 |
_aTankyrases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTranscriptional Activation _xdrug effects |
| 650 | 0 | 4 | _aWnt Signaling Pathway |
| 650 | 0 | 4 |
_abeta Catenin _xantagonists & inhibitors |
| 700 | 1 | _aNoulet, Fanny | |
| 700 | 1 | _aMercier, Marie-Cécile | |
| 700 | 1 | _aChoulier, Laurence | |
| 700 | 1 | _aEtienne-Selloum, Nelly | |
| 700 | 1 | _aGies, Jean-Pierre | |
| 700 | 1 | _aLehmann, Maxime | |
| 700 | 1 | _aLelong-Rebel, Isabelle | |
| 700 | 1 | _aMartin, Sophie | |
| 700 | 1 | _aDontenwill, Monique | |
| 773 | 0 |
_tOncotarget _gvol. 7 _gno. 38 _gp. 62194-62207 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.11552 _zAvailable from publisher's website |
| 999 |
_c26406151 _d26406151 |
||